Thin lips are not only a common cosmetic concern in patients with scleroderma, a condition that involves tightening and hardening of the skin among other effects on internal organs, but also can impact a person’s ability to chew, swallow, and sleep.
Scientists have discovered how the dangerous respiratory syncytial virus (RSV) defuses our immune response and, in doing so, have pinpointed an exciting new target for drug developers.
CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine.
Researchers from the University of Liverpool’s Center for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
A naturally occurring peptide called PEPITEM could potentially rejuvenate the immune response in older individuals and protect against “inflammaging,” which is widely believed to be the root cause of many age-related diseases.
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects. While responsible for saving many lives, this treatment sometimes causes cardiac damage that stiffens the heart and puts a subs…
Platelets play an essential role in wound healing. Underproduction can cause devastating bleeding, while overproduction increases the deadly risk of thromboses. Maintaining a constant level of platelets in the blood (homeostasis) is therefore vitally i…
A new study, published in the Journal of Experimental Medicine, shows that about 2% of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID-19. The …
Yevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an Assistant Professor of Dermatology at Harvard Medical School, and Guihong Wan, Ph.D., an Instructor of Dermatology at Massachusetts General Hospital…
The protein STAT3 helps the immune system to recognize leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to a study at the Karl Landsteiner University of Health Sciences (KL Krems).
